You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
At Astellas, we are dedicated to supporting and improving the lives of those impacted by cancer. One of the ways we provide this support is by working with patient advocacy organizations, such as The Leukemia and Lymphoma Society (LLS) – the world's largest voluntary health agency dedicated to blood cancers, including leukemia, lymphoma, Hodgkin's disease and myeloma.
To help brighten the darkest moments of patients’ cancer treatment journeys, LLS created the Light The Night campaign. A series of fundraising walks across the country, Light The Night benefits research to find blood cancer cures and improve the quality of life for patients and their families.
Sharing LLS’ mission to expand cancer research and support resources for patients, Astellas sponsored various Light The Night walks throughout October and November.
“The Light The Night initiative is a moving effort to drive cancer research, and we’re proud to support an event that brings hope to cancer patients and their families,” said Doug Noland, Head of Patient Experience at Astellas. “We look forward to continuing to work with LLS to help patients with blood cancers.”
At various Light The Night events, Astellas featured an employee-staffed booth to highlight our efforts to change tomorrow for patients. The booth also encouraged attendees to consider how they will change tomorrow to make a positive impact on the cancer community and society as a whole.
“It was a truly beautiful and inspiring event for all those affected by leukemia and lymphoma,” said Lauren Hicks, assistant director, Patient Experience, who attended the October 17 Light The Night event in Boston. “This disease has also personally affected me, as my father passed away from Non-Hodgkin’s Lymphoma at the age of 54. I was proud able to light my own Gold lantern in his honor.”
Learn more about LLS and their mission to cure blood cancers by visiting their website here.
Get only the email alerts you want.
For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.